Publisher Login
Manuscript Statistics
1
2
3
4
5
6
7
2025-04-29 | Browse: 35 | Download: 0
8
9
10
2025-04-28 | Browse: 30 | Download: 0
11
12
13
14
15
16
17
2025-04-28 | Browse: 27 | Download: 0
18
19
20
2025-04-27 | Browse: 32 | Download: 0
498 items Read more >>
1
"Dear Sir or Madam, Thank you very much. Overall, I am very pleased with the submission process. The only minor issue was the length ..."
[Read more]
"Dear Sir or Madam, Thank you very much. Overall, I am very pleased with the submission process. The only minor issue was the length of the review period; however, I understand that hyperspectral imaging is a highly specialized and technically demanding research topic. Therefore, it was not easy to find reviewer. Thank you. Kind regards, Mohamed El-Mahrouk "
[Collapse]
El-Mahrouk M, Langner C, Sucher R, Kniepeiss D. Introducing hyperspectral imaging as a novel tool for assessing donor liver quality during machine perfusion: A case report. World J Transplant 2025; 15(3): 102798
2
"I sincerely appreciate the journal's efficient editorial process and the valuable feedback provided by the reviewers, which greatly ..."
[Read more]
"I sincerely appreciate the journal's efficient editorial process and the valuable feedback provided by the reviewers, which greatly enhanced the quality of our manuscript. The communication throughout was clear and timely. However, I noticed that the final PDF version of the article appeared slightly informal, such as the lack of column formatting. A more standardized layout could further enhance the professional appearance of the publication. "
[Collapse]
Chen LH, Guo Q, Hu Y, Liu XH, Hu H, Chen HY, Liu CP, Li HF, Chen JD, Li GJ. Effectiveness and safety of blonanserin monotherapy for first-episode schizophrenia with and without prominent negative symptoms: A prospective study. World J Psychiatry 2025; 15(5): 103701
3
"I am highly satisfied with my experience with this journal. The manuscript editing process was meticulous and professional, with ..."
[Read more]
"I am highly satisfied with my experience with this journal. The manuscript editing process was meticulous and professional, with editors providing insightful suggestions that significantly improved the quality of my work. The publishing process was also efficient and transparent, keeping me informed at every stage. This evaluation attests to the journal's high credibility and dedication to academic excellence, and I hope it serves as a helpful reference for other authors considering submission. "
[Collapse]
Zheng WX, Liu LY. Urgent thrombolysis followed by percutaneous coronary intervention for the simultaneous acute cardio-cerebral ischemic attack: A case report. World J Clin Cases 2025; 13(21): 105816
4
"I am incredibly honored and delighted to have my article accepted and published in World Journal of Psychiatry. This achievement is ..."
[Read more]
"I am incredibly honored and delighted to have my article accepted and published in World Journal of Psychiatry. This achievement is not only a significant milestone for me as an author but also a testament to the rigorous editorial standards and commitment to quality of this esteemed publication. I would like to express my sincere gratitude to the editorial team at World Journal of Psychiatry. Their professional guidance, constructive feedback, and meticulous review process have been instrumental in shaping the final version of the article. Their expertise and attention to detail have significantly enhanced the quality and clarity of my work. "
[Collapse]
Wang S, Qin JL, Yang LL, Ji YY, Huang HX, Gao XS, Zhou ZM, Guo ZR, Wu Y, Tian L, Ni HJ, Zhou ZH. Structural network communication differences in drug-naive depressed adolescents with non-suicidal self-injury and suicide attempts. World J Psychiatry 2025; 15(5): 102706
5
"The World Journal of Experimental Medicine excels through its exceptionally efficient peer-review system, combining rigorous ..."
[Read more]
"The World Journal of Experimental Medicine excels through its exceptionally efficient peer-review system, combining rigorous evaluations with remarkable turnaround times. Its transparent editorial process and reviewers' prompt, constructive feedback accelerate publication while maintaining outstanding scientific standards. This commitment to both quality and timeliness makes it a standout choice for researchers seeking timely, high-impact dissemination "
[Collapse]
Mejía Delgado EM, Quiroz-Aldave JE, Durand-Vásquez MDC, Aldave-Pita LN, Fuentes-Mendoza JM, Concepción-Urteaga LA, Paz-Ibarra J, Concepción-Zavaleta MJ. Immunomodulatory effect of allium sativum in type 2 diabetes mellitus. World J Exp Med 2025; 15(2): 103481
6
"We sincerely appreciate the efficient editorial handling of our manuscript. The review process was thorough and timely, and we are ..."
[Read more]
"We sincerely appreciate the efficient editorial handling of our manuscript. The review process was thorough and timely, and we are fully satisfied with the outcome. As the revisions have been addressed to the reviewers' satisfaction, we have no further comments and consider the editorial process to have been conducted excellently. "
[Collapse]
Fan LW, Shang C, Lin Q, Tian YT, Xu DK. Clinicopathological characteristics and prognostic outcomes of pregnancy-associated colorectal cancer: A 24-year experience. World J Gastroenterol 2025; 31(17): 106508
7
"Firstly We would like to thank editorial staff and reviewers for an amazing job . Second We tried our best to make this work good ..."
[Read more]
"Firstly We would like to thank editorial staff and reviewers for an amazing job . Second We tried our best to make this work good and show research's how the anxieties and depression effects on the liver cancer patients compared with life quality . We think it’s important topic and should focus on this topic on future. "
[Collapse]
Hendi M, Zhang B, Lv JM, Cai XJ. Factors influencing anxiety and depression in advanced hepatocellular carcinoma patients and their impact on quality of life. World J Psychiatry 2025; 15(5): 104995
8
"We are pleased to submit our manuscript to World Journal of Psychiatry and are very grateful for the opportunity to share our research ..."
[Read more]
"We are pleased to submit our manuscript to World Journal of Psychiatry and are very grateful for the opportunity to share our research through your platform. The entire process was very efficient. The peer review was thorough, thoughtful and constructive and helped strengthen the final manuscript. The editorial team was professional, responsive and supportive at every stage of the process. I highly recommend this journal to researchers and colleagues seeking a positive publishing experience. "
[Collapse]
Zhang R, Wang MY, Zhang XQ, Gong YW, Guo YF, Shen JH. Self-care activities mediate self-perceived burden and depression in Chinese patients with type 2 diabetes. World J Psychiatry 2025; 15(5): 104766
9
"We've been thoroughly impressed with this journal's editorial process. The peer-review is both rigorous and thoughtful, with reviewers ..."
[Read more]
"We've been thoroughly impressed with this journal's editorial process. The peer-review is both rigorous and thoughtful, with reviewers providing genuinely helpful suggestions to improve manuscripts. What stands out most is the remarkable efficiency - reviews are typically completed within 4-6 weeks, which is noticeably quicker than similar journals in integrative medicine. The online submission system is user-friendly, and we particularly appreciate the journal's clear communication at every stage. The editorial team has mastered the delicate balance between maintaining strict scientific standards while being genuinely supportive of authors. Published articles consistently demonstrate excellent quality, reflecting the journal's commitment to advancing meaningful research. With its efficient processes, high standards, and focus on interdisciplinary work, this journal has become a valued platform for sharing innovative research in microbiome and traditional medicine. "
[Collapse]
Jia JL, Han JH, Pang R, Bi W, Liu B, Yang K. Predictors of poor prognosis in long-term survivors of differentiated thyroid cancer with psychiatric disorders. World J Psychiatry 2025; 15(5): 103628
10
"Dear Chief Editor, Greetings of the day. We are highly grateful to all the reviewers, editors and publication staff for always being ..."
[Read more]
"Dear Chief Editor, Greetings of the day. We are highly grateful to all the reviewers, editors and publication staff for always being so professional and meticulous. The anonymous reviews always helps and guide the authors to make corrections in their manuscript. This unbiased process makes the best version of the article. The editing services by BPG are excellent. Thanks Best Regards Dr. Arvind Kumar Morya "
[Collapse]
Singh A, Morya AK, Nishant P, Sinha S. Bidirectional link between mood disorders and diabetic retinopathy. World J Psychiatry 2025; 15(5): 102540
11
"Overall, the publication experience was highly positive, reflecting the journal’s dedication to supporting authors and advancing ..."
[Read more]
"Overall, the publication experience was highly positive, reflecting the journal’s dedication to supporting authors and advancing science. The collaborative efforts of the editorial team, reviewers, and production staff are commendable. For future improvements, consider enhancing the online submission system. Thank you for the opportunity to contribute to your journal’s mission. We look forward to continued collaboration. "
[Collapse]
Tian QJ, Zhang LJ, Zhang Q, Liu FC, Xie M, Cai JZ, Rao W. Protein-losing enteropathy and multiple vasculature dysplasia in LZTR1-related Noonan syndrome: A case report and review of literature. World J Gastroenterol 2025; 31(17): 105347
12
"I think your journal is very good in processing speed. It is easy and smooth to operate the submission system. The peer review process ..."
[Read more]
"I think your journal is very good in processing speed. It is easy and smooth to operate the submission system. The peer review process is fast and excellent. The reviewer comments are of high quality. The publication after acceptance of the mansucript is very fast. I am very satistifed with any dimensions of your journal. Thanks for your kind work. "
[Collapse]
Zhao CY, Xu N, Dong H, Chai NL, Linghu EQ. Effect of sex on the outcomes of peroral endoscopic myotomy for the treatment of achalasia. World J Gastroenterol 2025; 31(17): 104579
13
"The World Journal of Gastroenterology maintains a high academic standard in the research of gastrointestinal diseases and continues ..."
[Read more]
"The World Journal of Gastroenterology maintains a high academic standard in the research of gastrointestinal diseases and continues to improve. During the review process, the comments provided by the reviewers are scientific and reasonable, which greatly enhances the quality of the manuscripts. From the submission of the manuscript to its official online publication, we truly appreciate the dedicated and responsible attitude of the entire editorial team, including assistant editors, scientific editors, peer reviewers, the editor-in-chief, the company's editor-in-chief, language editors, and production editors, in handling the manuscripts, which ensures their quality. In the future, we will continue to submit high-quality manuscripts to the World Journal of Gastroenterology. "
[Collapse]
Zhao CF, Liu XL, Wu NB, Xu ZF. Triglyceride-glucose index as a prognostic indicator in advanced gastric cancer: Insights and future research. World J Gastroenterol 2025; 31(17): 104794
14
"I am very grateful to the journal for accepting my manuscript. The article has been reviewed several times by reviewers, and I have ..."
[Read more]
"I am very grateful to the journal for accepting my manuscript. The article has been reviewed several times by reviewers, and I have made many revisions. In the process of submission, I felt the review experts and editorial staff of the rigorous and serious style of work. In a word, I'm very satisfied. "
[Collapse]
Lv SP, Qin LL, Mou H, Huang T, Wang KQ. Multimodal imaging techniques for the diagnosis of congenital left renal arteriovenous fistula: A case report. World J Clin Cases 2025; 13(21): 104062
15
"Evaluation of the Journal's Credibility The World Journal of Gastroenterology maintains high academic standards and demonstrates a ..."
[Read more]
"Evaluation of the Journal's Credibility The World Journal of Gastroenterology maintains high academic standards and demonstrates a rigorous commitment to advancing gastrointestinal research. The journal’s reputation is well-established within the scientific community, supported by its inclusion in prominent databases and adherence to transparent editorial practices. The clarity of submission guidelines and ethical publishing policies further reinforce its credibility. Evaluation of the Journal’s Peer Review Process The peer review process was both thorough and constructive. Reviewers provided detailed, actionable feedback that significantly strengthened the manuscript. The editorial team ensured timely communication at every stage, and the double-blind review system upheld fairness and impartiality. However, a slightly faster turnaround time for initial reviews could further enhance author experience. General Comments The collaborative efforts of the editorial team—including language editors, production staff, and peer reviewers—were instrumental in refining the manuscript. The F6Publishing platform is user-friendly, and the support from the editorial office was consistently professional and responsive. We appreciate the journal’s dedication to open access, which maximizes the visibility and impact of published work. A minor suggestion would be to expand the scope of author resources (e.g., detailed formatting templates or video tutorials) to assist first-time submitters. Final Remarks Publishing with World Journal of Gastroenterology has been a positive and rewarding experience. We commend the journal for its efficiency, transparency, and commitment to scientific excellence. This collaboration has encouraged us to consider submitting future work to the journal. "
[Collapse]
Wu YP, Zhou JX, Wu HB, Wu DP, Qin LZ, Qin B, Xu XY, Yehya SAA, Cheng Y. Clinical characteristics and risk factors of esophageal reflux hypersensitivity: A multicenter study. World J Gastroenterol 2025; 31(17): 105281
16
"The World Journal of Gastroenterology demonstrated exceptional efficiency in handling our article and managing the publication process. ..."
[Read more]
"The World Journal of Gastroenterology demonstrated exceptional efficiency in handling our article and managing the publication process. Their streamlined approach, prompt communication, and thorough peer review ensured a smooth journey from submission to publication. The journal's commitment to timely dissemination of research was evident in their rapid turnaround times and professional editorial support, enhancing the overall publication experience for authors. "
[Collapse]
Gadour E, AlQahtani MS. Illuminating the black box: Machine learning enhances preoperative prediction in intrahepatic cholangiocarcinoma. World J Gastroenterol 2025; 31(17): 106592
17
"We are highly satisfied with the overall process of publication and peer review. The prepared tables in the online full-text article ..."
[Read more]
"We are highly satisfied with the overall process of publication and peer review. The prepared tables in the online full-text article were clear, accurate, and well-organized, reflecting the quality of the journal’s editing standards. We appreciated the adherence to academic rules and norms throughout the process. Furthermore, the peer review was conducted anonymously, fairly, and objectively, providing valuable feedback that helped us significantly improve our manuscript. The period of publication was reasonable, and the detection report for academic misconduct added transparency and credibility. Overall, we are pleased with the professional and efficient handling of our submission. "
[Collapse]
Karagiannidis E, Papazoglou AS, Samaras A, Nasoufidou A, Zormpas G, Tagarakis G, Theodoropoulos KC, Papadakis M, Tzikas A, Fragakis N, Kassimis G. Intravascular ULTRA sound-guided percutaneous coronary intervention in patients with STEMI: Rationale and design of the ULTRA-STEMI trial. World J Cardiol 2025; 17(4): 106072
18
"Thank you for always recommending reviewers for me, even though it has taken more than a year. However, the publication fee of the ..."
[Read more]
"Thank you for always recommending reviewers for me, even though it has taken more than a year. However, the publication fee of the journal is too high. I made great efforts to get this sum of money reimbursed. I hope that the publication fee of the journal can be reduced in the future. "
[Collapse]
Ye XW, Zhang HX, Li Q, Li CS, Zhao CJ, Xia LJ, Ren HM, Wang XX, Yang C, Wang YJ, Jiang SL, Xu XF, Li XR. Scientometric analysis and historical review of diabetic encephalopathy research: Trends and hotspots (2004-2023). World J Diabetes 2025; 16(5): 91200
19
"I am deeply grateful for the outstandingly high - efficiency work of the journal. Also, the reviewers' comments are of great value. ..."
[Read more]
"I am deeply grateful for the outstandingly high - efficiency work of the journal. Also, the reviewers' comments are of great value. Their constructive suggestions provide us with new perspectives and insights to improve our work. Once again, I would like to express our sincere gratitude for publishing this letter. "
[Collapse]
Wei H, Mai ZL, Ma BT, Chang B. Creeping fat: A promising radiological predictor in small bowel Crohn’s disease. World J Gastroenterol 2025; 31(16): 105186
20
"The review speed of the article is impressively fast, with the editorial team ensuring a smooth and efficient submission-to-publication ..."
[Read more]
"The review speed of the article is impressively fast, with the editorial team ensuring a smooth and efficient submission-to-publication process. The review experts provide highly professional and insightful opinions, offering constructive feedback that significantly enhances the quality of the manuscript. Their expertise and attention to detail are truly commendable. Additionally, the editor responsible for formatting and correcting the article in the later stage is exceptionally diligent, responsible, and patient. They meticulously check every detail, from grammar and punctuation to formatting consistency, ensuring the final version meets the highest academic standards. Their dedication and thoroughness greatly contribute to the polished and professional presentation of the work. Overall, the entire team's commitment to excellence makes the publication process both pleasant and rewarding for authors. "
[Collapse]
Xu XT, Jiang MJ, Fu YL, Xie F, Li JJ, Meng QH. Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis. World J Hepatol 2025; 17(4): 104890
18586 items Read more >>
1
"The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. ..."
[Read more]
"The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. Methods are appropriate and effective. Results are appropriate of methods and are authentic. Tables and biostatistics data are perfect. The references are adequate of topic. Language of article is satisfied."
[Collapse]
Chen LQ, Wu CY, Wu SJ, Ye K. Laparoscopic surgical approaches for various locations of gastrointestinal stromal tumours. World J Clin Cases 2025; 13(21): 105559
2
"In this editorial, the authors discussed an article reporting the significance of the triglyceride-glucose (TyG) index in predicting ..."
[Read more]
"In this editorial, the authors discussed an article reporting the significance of the triglyceride-glucose (TyG) index in predicting prognosis and response to immunotherapy. Unfortunately, it is difficult to assess the study’s significance, as the editorial does not provide actual probability for each comparison. Furthermore, the manuscript lacks clarity, as it contains numerous contradictory statements.
In the sections titled “The TyG Index as a Prognostic Factor in GC” and “Exploring the Relationship Between TyG and Immunotherapy Response”, the authors emphasize that a higher TyG index is associated with better outcomes and an improved response to immunotherapy. However, in the subsequent section “Mechanisms Linking TyG to Cancer Progression and Immune Function”, they state that a high TyG index may promote tumor cell proliferation, inhibit apoptosis, and reduce the response rate to immunotherapy.
The authors should revise the manuscript to resolve these inconsistencies and improve overall clarity."
[Collapse]
Zhao CF, Liu XL, Wu NB, Xu ZF. Triglyceride-glucose index as a prognostic indicator in advanced gastric cancer: Insights and future research. World J Gastroenterol 2025; 31(17): 104794
3
"Helicobacter pylori is still a significant health problem in developed and developing countries. Its presence is associated with ..."
[Read more]
"Helicobacter pylori is still a significant health problem in developed and developing countries. Its presence is associated with several important consequences. Its eradication is, therefore, an essential objective in cases where its presence has been demonstrated. It is well known that inhibiting gastric acid secretion is necessary for the combination of antibiotics used for its eradication to be effective. In recent years, a new drug with a strong antisecretory effect has been introduced into our pharmaceutical quiver, Vonoprazan (VPZ), which is a member of the potassium competitive acid blockers. In the commented study (Ozercan M et al., Vonoprazan and proton pump inhibitors: which is superior for Helicobacter pylori eradication? World J Gastroenterol 2025; 31(17): 103156), the authors commented on the safety and efficacy of VPZ with the safety and effectiveness of proton pump inhibitors (PPIs), in the eradication of Helicobacter pylori. By reviewing the relevant studies, they found that VPZ administration had a higher rate of efficacy and a lower rate of side effects compared to PPIs. They concluded that despite its higher cost, VPZ is an economically and medically superior therapeutic strategy compared to PPIs. Helicobacter pylori eradication therapy may be a significant problem in daily clinical practice in some proportion of patients, particularly in patients over 60 years of age, for whom the avoidance of the side effects of treatment should be a key objective. This task could be achieved by using fewer antibiotics combined with VPZ, e.g. only amoxicillin plus VPZ which is an important alternative therapy shortly.
The paper by Ozercan M et al. is a comprehensive but clear review of the data on the usefulness of VPZ in the treatment of Helicobacter pylori infection, providing clear guidelines for the use of the drug in daily clinical practice. "
[Collapse]
Ozercan M, Tawheed A, Ismail A, Amer MS, El-Kassas M. Vonoprazan and proton pump inhibitors: Which is superior for Helicobacter pylori eradication? World J Gastroenterol 2025; 31(17): 103156
4
"This is the first United Kingdom study to report the frequency of death in patients presenting with paracetamol overdose-related acute ..."
[Read more]
"This is the first United Kingdom study to report the frequency of death in patients presenting with paracetamol overdose-related acute hepatic failure.Paracetamol overdose (POD) is the most common cause of acute hepatic failure (AHF) in the United Kingdom. Without urgent orthotopic liver transplant (OLT), mortality is high. Indeed, Paracetamol overdose (POD) is the most common cause of acute hepatic failure (AHF) in the United Kingdom. Without urgent orthotopic liver transplant (OLT), mortality is high.
This is an 18-year single-centre retrospective cohort study based in a national liver transplant centre. 524 participants were identified from a departmental database and included if they had AHF from suspected POD and received a psychiatric assessment for OLT.Among 524 patients undergoing psychiatric assessment for OLT, there were 102 in-episode deaths (19.5%). This indicates a need for ongoing assessor training and support, and (inter) national comparisons of practice"
[Collapse]
Impey ORE, Baker JD, Smyth RS, Potts SG. Death after psychiatric contraindications to urgent liver transplant for paracetamol overdose. World J Transplant 2025; 15(3): 101865
5
"Paediatric liver transplantation (PLT) is a life-saving procedure for children with advanced liver disease or hepatoblastoma. The ..."
[Read more]
"Paediatric liver transplantation (PLT) is a life-saving procedure for children with advanced liver disease or hepatoblastoma. The number of available grafts is limited in relation to the number of children on PLT waiting list. One of the limitations is the donor obesity. Donors’ obesity is strongly associated with hepatic steatosis which can affect graft function by impairing microcirculation and maximizing the potential of ischemia-reperfusion injury. This important study faces this problem and offers a possible solution. New strategies to optimize the grafts before PLT such as normothermic regional perfusion and ex vivo liver perfusion can potentially mitigate the risk of using grafts from obese donors.The study in particular treats new strategies to optimize the grafts before PLT such as normothermic regional perfusion and ex vivo liver perfusion can potentially mitigate the risk of using grafts from obese donors.
"
[Collapse]
Alnagar A, Amgad A, Grammatikopoulos T, Kyrana E. Impact of donor obesity on paediatric liver transplantation; current evidence and potentials for graft pool expansion. World J Transplant 2025; 15(3): 103015
6
"Very important study on the management of patients with doner-specific antibodies detected
by Luminex pre-transplantation. ..."
[Read more]
"Very important study on the management of patients with doner-specific antibodies detected
by Luminex pre-transplantation. Pretransplant low-level donor-specific antibodies (DSAs) detected by the Luminex platform are associated with favorable graft outcomes after 1 year and 10 years in kidney transplant recipients. This study highlighted the appropriate immunosuppressive induction and maintenance protocols. These patients experienced low rates of acute rejection and sustained satisfactory long-term graft function and survival.
"
[Collapse]
Abbas K, Mubarak M, Musharraf W, Hafeez AR, Aziz T, Zafar MN. Impact of low-level pretransplant donor-specific antibodies detected by the Luminex platform on acute rejection and long-term graft survival. World J Transplant 2025; 15(3): 104308
7
"Very interesting study on a critical point involving transplantatio. Indeed,Fertility preservation and pregnancymanagement are critical ..."
[Read more]
"Very interesting study on a critical point involving transplantatio. Indeed,Fertility preservation and pregnancymanagement are critical considerations for patients undergoing organtransplantation.
This mini-review explores advancements in cryopreservationtechniques, pre-conception counseling, and multidisciplinary strategies forsafe pregnancies post-transplantation. Emphasis is placed on balancing maternalhealth, graft function, and fetal outcomes. Fertility preservation and pregnancymanagement are critical considerations for patients undergoing organtransplantation."
[Collapse]
Lazarov V, Naseva E, Miteva DG, Tomov LP, Shumnalieva R, Peruhova M, Velikova T. Advances in fertility preservation and pregnancy care for transplant patients. World J Transplant 2025; 15(3): 103958
8
"Heart transplantation is a life-saving procedure for many people throughout the world. However, organ availability remains a major ..."
[Read more]
"Heart transplantation is a life-saving procedure for many people throughout the world. However, organ availability remains a major limiting factor affecting transplant volume. This mandates that innovation must take place to increase the supply of donor organs. This study outline several of the proposed strategies, including splitting the donor heart to provide multiple partial heart transplants, domino partial heart transplantation, changes in legislation including opt-out legislation, and xenotransplantation.
"
[Collapse]
Alexander B, Javed H, Furrukh A, Joshi K, Steen L, Rajab TK. Innovative strategies to increase cardiac donor availability. World J Transplant 2025; 15(3): 102768
9
"The impact of major cardiovascular events on the outcomes of kidney transplant patients is extremely important. In this original study, ..."
[Read more]
"The impact of major cardiovascular events on the outcomes of kidney transplant patients is extremely important. In this original study, the authors report the role of the blood levels of uric acid on the frequency of MACEs. the statitstical analysi here reported i well done and relevant. MACEs occurred in 145 of 545 (26.6%) KT recipients. The most prevalent comorbidities were hypertension (87%), dyslipidemia (78%), secondary hyperparathyroidism (68%), HU (63%) and anemia (33%). In the multivariate logistic regression model, the most significant factors associated with MACEs were previous CV events [odds ratio (OR) = 70.6, 95%CI: 24.9–200.1], left ventricular hypertrophy (LVH) (OR = 12.6, 95%CI: 2.7– 58.3), HU treatment (OR = 4.3, 95%CI: 2.4–7.6), and anemia (OR = 5.3, 95%CI: 2.9–9.8). Effect modification by the presence of HU revealed that independent factors associated with MACEs were age (OR = 1.03, 95%CI: 1.0–1.1), previous CV events (OR = 41.7, 95%CI: 13.6–127.6), LVH (OR = 15.3, 95%CI: 2.0–116.6), HU treatment (OR = 2.5, 95%CI: 1.3–4.6) and anemia (OR = 5.4, 95%CI: 2.8–10.5). Effect modification by UA levels dichotomized at 475 μmol/L (very high level of UA) revealed that HU treatment was not associated with MACEs in groups with or without very high UA levels.
"
[Collapse]
Junk E, Tzivian L, Folkmane I, Folkmanis K, Jushinskis J, Strazda G, Folkmanis V, Kuzema V, Petersons A. Major adverse cardiovascular events and hyperuricemia as an effect-modifying factor in kidney transplant recipients. World J Transplant 2025; 15(3): 102287
10
"Even this is a case report, its importance is due to the rarity of the problematis exposed and the treatment succesful. Despite ..."
[Read more]
"Even this is a case report, its importance is due to the rarity of the problematis exposed and the treatment succesful. Despite numerous challenges, the patient achieved a successful recovery with satisfactory graft function and was free from lymphorrhea/lymphedema in her left lower limb 3 years post-transplantation. This case underscores the importance of robust infection control during both the pre- and post-transplantation phases and highlights the potential of LVA as a treatment option for managing lymphorrhea and infections in patients with liver cirrhosis.
"
[Collapse]
Wu TW, Hou TY, Yang JCS, Wang CC. First report of successful liver transplantation following supermicrosurgical lymphaticovenous anastomoses for lymphorrhea with intractable infection: A case report. World J Transplant 2025; 15(3): 101496
11
" De novo malignancies (DNMs) are a major concern, accounting for 20%-25% of deaths in LT recipients surviving beyond the early ..."
[Read more]
" De novo malignancies (DNMs) are a major concern, accounting for 20%-25% of deaths in LT recipients surviving beyond the early post-transplant period. Non-melanoma skin cancers, particularly squamous cell carcinoma are the most prevalent DNMs. Other significant malignancies include Kaposi's sarcoma, post-transplant lymphoproliferative disorders, and various solid organ cancers, including head and neck cancers.
This is a very interesting paper over the issue of cancers de novo in liver transplant patients
"
[Collapse]
Singh A, Singh C, Dhaliwal A, Singh N, Kumar V, Sohal A, Schneider J. Incidence, screening, and management of de novo malignancies in liver transplant patients: A review. World J Transplant 2025; 15(3): 101046
12
"A rather good paoer as many others on the same issue. the paper stresses the impact of covid 19 on the transplanted patients or on ..."
[Read more]
"A rather good paoer as many others on the same issue. the paper stresses the impact of covid 19 on the transplanted patients or on the patients waiting to be transplanted. important paper for the physicians dealing with transplantation. the recommendation offered by the authors should be carefully followed to reduce the impact of covid 19 over the transplant activity"
[Collapse]
Bozkurt HB, Özdemir Ö. Changes regarding solid organ transplantation during the COVID-19 pandemic. World J Transplant 2025; 15(3): 100591
13
"The article adheres to the ethical standards of the institutional and national research committees, as well as with the 1964 Helsinki ..."
[Read more]
"The article adheres to the ethical standards of the institutional and national research committees, as well as with the 1964 Helsinki Declaration and its later amendments or equivalent ethical guidelines. The study methods are robust, using a large national database based on retrospective data, and appropriate statistical analysis, allowing reproducibility. Results are authentic and statistically validated, offering meaningful insights into cardiovascular risks among metabolically healthy obese postmenopausal women. Tables and figures are clear, well-constructed, and support the data effectively. References are up-to-date and relevant to the field. The manuscript is written clearly and concisely. Language throughout the article is clear, academic, and concise. However, the study acknowledges limitations due to retrospective design and database reliance. Furthermore, the study lacks detailed BMI distribution data, and, as noted by the authors, it does not explore the potential impact of lifestyle factors on MACCE outcomes. No long-term follow-up data is recorded and the study population is exclusively composed of postmenopausal women who required hospitalization, which may limit the generalizability of the findings to the broader outpatient population."
[Collapse]
Pingili A, Desai R, Vempati R, Vemula M, Lakkimsetti M, Madhavaram H, Nanjundappa A, Singh S, Sunkara P, Gummadi J. Prevalence and impact of metabolically healthy obesity on cardiovascular outcomes in postmenopausal women and disparities: An age-matched study. World J Cardiol 2025; 17(4): 105842
14
"1. Is the patient's age compatible with the diagnosis of congenital renal arteriovenous fistula? What is the common age group for ..."
[Read more]
"1. Is the patient's age compatible with the diagnosis of congenital renal arteriovenous fistula? What is the common age group for a typical congenital RAVF?
2. Instead of summarising the details of the case under the conclusion, a 'take home' message including when to suspect, what to do can be helpful for the reader."
[Collapse]
Lv SP, Qin LL, Mou H, Huang T, Wang KQ. Multimodal imaging techniques for the diagnosis of congenital left renal arteriovenous fistula: A case report. World J Clin Cases 2025; 13(21): 104062
15
"1. The introduction section is lengthy and packed with information. The purpose of the introduction is to inform the reader about ..."
[Read more]
"1. The introduction section is lengthy and packed with information. The purpose of the introduction is to inform the reader about the background, which can be a brief overview rather than an exhaustive one.
2. The discussion can include the cost and other potential limitations of circulating tumor DNA.
3. The likely future prospects such as need for a multicentre / institutional prospective randomised trial can be included in the discussion. "
[Collapse]
Zhou XY, Jiang YJ, Guo XM, Han DH, Liu Y, Qiao Q. Application of circulating tumor DNA liquid biopsy in nasopharyngeal carcinoma: A case report and review of literature. World J Clin Cases 2025; 13(21): 105066
16
"1. The order of the case report can be changed to bring clarity and understanding in the following manner. Chief complaints to be ..."
[Read more]
"1. The order of the case report can be changed to bring clarity and understanding in the following manner. Chief complaints to be followed by other history (past, present, family), physical examination, laboratory findings, imaging in a sequence so that the reader can appreciate the methodical work up.
2. The conclusion can include the importance of imaging (MRI > US) in avoiding unnecessary surgery"
[Collapse]
Ali S, Anjum A, Nasir KM, Khalid AR, Shahzad F, Nashwan AJ. Ovarian vein thrombosis mimicking acute appendicitis: A case report. World J Clin Cases 2025; 13(21): 103525
17
"1. The title does not indicate the study type. To include the type of article (descriptive review)
2. General principles of Gastro ..."
[Read more]
"1. The title does not indicate the study type. To include the type of article (descriptive review)
2. General principles of Gastro Intestinal Stromal Tumor resection can be outlined (minimal handling, avoiding tumor rupture, maintaining surgical margins, etc)
3. The management can be summarised in a table/algorithm format
4. Inclusion of more figures can be helpful in better understanding"
[Collapse]
Chen LQ, Wu CY, Wu SJ, Ye K. Laparoscopic surgical approaches for various locations of gastrointestinal stromal tumours. World J Clin Cases 2025; 13(21): 105559
18
"In this editorial, the authors emphasize the importance of Creeping Fat (CF) as a predictor indicating poor prognosis in Crohn's ..."
[Read more]
"In this editorial, the authors emphasize the importance of Creeping Fat (CF) as a predictor indicating poor prognosis in Crohn's disease. The authors speculate that CF is associated with specific characteristics of small bowel Crohn's disease and present several reports to support this hypothesis. However, their description is more narrative than statistical. To strengthen their speculation, it would be better to include numerical data. Overall, while the editorial raises interesting points about CF, it would benefit from more quantitative evidence."
[Collapse]
Wei H, Mai ZL, Ma BT, Chang B. Creeping fat: A promising radiological predictor in small bowel Crohn’s disease. World J Gastroenterol 2025; 31(16): 105186
19
"In addition to the discussion focusing on the morphalogy and volume of the pituitary neuroendocrine tumor in the editorial, the ..."
[Read more]
"In addition to the discussion focusing on the morphalogy and volume of the pituitary neuroendocrine tumor in the editorial, the function status of a pituitary neuroendocrine tumor, target organs response, relevant homones, permissive action of hormone, and other factors should be addressed. Some tumors are large in size, but their functions are weak and secret less hormones, result in mild or moderate hazard; vice versa. "
[Collapse]
Yang JS. Prognosis value of pituitary neuroendocrine tumor volume. World J Radiol 2025; 17(4): 106186
20
"Using four-dimensional flow magnetic resonance imaging technique for the evaluation of vascular flow hemodynamics is novel attempt. ..."
[Read more]
"Using four-dimensional flow magnetic resonance imaging technique for the evaluation of vascular flow hemodynamics is novel attempt. The reviewer compliments this editorial for its rich content. Adverse the weaknesses of it are not neglected, as following:
It’s a study of small sample, so it’s results and conclusion had better not be expressed as promising. The author commented on the study by Leesmidt et al should focus on the feasibility. Leesmidt et al said that superior and inferior mesenteric arteries were investigated and using Duplex ultrasound as a control.In fact, color Doppler ultrasound can measure the diameter and flow velocity of superior mesenteric artery reliable and conveniently, but it’s challenging to measure the diameter and flow velocity of inferior mesenteric artery. It’s hard to visualize the inferior mesenteric artery(vein). Measurement of the diameter and flow velocity of superior mesenteric vein is not so easy as that for the superior mesenteric artery.
The author of this editorial did not raise inquiry of this. In this editorial, the author said“Duplex ultrasound is a non-radiative tool for obtaining vascular flow velocity information but has limitations in larger patients due to reduced acoustic windows and operator dependency.”. It should be specific, the evaluation of superior mesenteric artery is almost not handicapped by acoustic windows and operator dependency. It’s hard to follow that“The study provides valuable insights into the hemodynamics of abdominal vessels in children.”in this editorial. The “Conclusion”should focus on the additional role of four-dimensional flow magnetic resonance imaging for blood vessels and hemodynamics.
Noteably, the reviewer checked the original article, and found that there is no involving of the inferior mesenteric artery(vein) in that article.
"
[Collapse]
Yang JS. Promising four-dimensional flow magnetic resonance imaging technique for vascular flow analysis in children. World J Radiol 2025; 17(4): 106185
15246 items Read more >>
Peer-Reviewers and Manuscript Statistics
- Editorial board members
- 2266
- Peer-reviewers
- 30650
- Manuscripts received today
- 3
- Manuscript reviews today
- 3
- Unhandled manuscripts today
- 188
- Active peer-reviewers today
- 444
- Reviewer acceptance today
- 11
- Reviewer refusals today
- 5
- Total accepted manuscripts
- 35825
- Total rejected manuscripts
- 41505
- Total peer-reviewers
- 4206649
- Total submissions
- 34129
1
2
3
4
5
6
7
8
9
10
2025-09-20 | Browse: 3303 | Download: 447
11
2025-09-20 | Browse: 1575 | Download: 332
12
2025-09-20 | Browse: 1851 | Download: 322
13
14
2025-09-20 | Browse: 1556 | Download: 274
15
2025-09-20 | Browse: 2107 | Download: 319
16
2025-09-20 | Browse: 2654 | Download: 386
17
2025-09-20 | Browse: 1809 | Download: 307
18
2025-09-20 | Browse: 1706 | Download: 297
19
20
2025-09-20 | Browse: 1811 | Download: 326
58388 items Read more >>
1
2025-04-30 | Browse: 19 | Download: 33
2
3
4
5
6
7
8
9
10
11
12
13
2025-04-27 | Browse: 27 | Download: 47
14
15
16
2025-04-27 | Browse: 26 | Download: 44
17
18
19
20
2025-04-27 | Browse: 35 | Download: 54
9460 items Read more >>
68684 items Read more >>
1
"The current study is very interesting as the authors addressed the role of gut micro biota in pathogenesis of chronic hepatitis B ..."
[Read more]
"The current study is very interesting as the authors addressed the role of gut micro biota in pathogenesis of chronic hepatitis B infection. They reported that the abundance of Dorea varies significantly across various stages of liver fibrosis, making it a potential microbial marker for identifying the onset and progression of liver fibrosis. This useful conclusion will pave the way for modification of treatment strategy of chronic hepatitis B infection However, I have two comments: 1-The selection of patients with a wide range of age : 18-80 may have an impact on the results. Previous studies have sown as individuals age, the gut microbiota undergoes significant changes in composition, diversity, and functionality , which have been linked to various health conditions, including cognitive decline and inflammatory diseases. 2-It would have been better to select two equal groups of patients from the start: one group with hepatic fibrosis and the other without fibrosis .Having the equal or nearly equal groups would make statistical analysis more fair as the groups already studied had one with 35 patients and the other with 102 patients. "
[Collapse]
Zhu Y, Geng SY, Chen Y, Ru QJ, Zheng Y, Jiang N, Zhu FY, Zhang YS. Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis. World J Gastroenterol 2025; 31(16): 105985
2
"The authors have made a significant contribution by uncovering the role of the Interleukin-36 (IL-36) subfamily in liver cirrhosis, ..."
[Read more]
"The authors have made a significant contribution by uncovering the role of the Interleukin-36 (IL-36) subfamily in liver cirrhosis, particularly highlighting the relationship between these cytokines and gut microbiota. This work provides a fresh perspective on the gut-liver axis, demonstrating how an imbalance in the gut microbiome might contribute to liver disease progression through inflammatory cytokine signaling. The innovation of the study lies in its identification of IL-36 cytokines, such as IL-36α, IL-36γ, IL-36Ra, and IL-38, as crucial players in the inflammatory processes associated with liver cirrhosis. By correlating these cytokines with gut microbiota alterations, the authors open new avenues for potential biomarkers and therapeutic targets in liver disease management. Their findings suggest that the IL-36 subfamily could help us better understand the pathophysiological mechanisms underlying liver cirrhosis and its association with dysbiosis in the gut microbiome. However, a notable limitation of the study is the lack of mechanistic exploration of how IL-36 cytokines mediate these effects in the liver. While the paper discusses correlations between IL-36 subfamily levels and gut microbiota, the underlying mechanisms linking these factors to liver cirrhosis progression are not fully explored. Further research into how IL-36 cytokines influence microbiota composition and how they interact with liver disease would enhance the understanding of the gut-liver axis. "
[Collapse]
Pan YZ, Chen WT, Jin HR, Liu Z, Gu YY, Wang XR, Wang J, Lin JJ, Zhou Y, Xu LM. Correlation between the interleukin-36 subfamily and gut microbiota in patients with liver cirrhosis: Implications for gut-liver axis imbalance. World J Hepatol 2025; 17(4): 105660
3
"This paper evaluates the impact of sex on the outcomes of peroral endoscopic myotomy (POEM) in the treatment of esophageal achalasia. ..."
[Read more]
"This paper evaluates the impact of sex on the outcomes of peroral endoscopic myotomy (POEM) in the treatment of esophageal achalasia. POEM is concluded to be a safe and effective treatment for both men and women, with women potentially deriving greater benefit than men. The study further suggests that sex may influence the therapeutic effect and symptom improvement after POEM, with hormonal factors being particularly important in women. The short-term success rate of POEM surgery is 96.52%. Success is improving the Eckardt score to 3 or less without additional treatment. These results indicate that POEM is a highly effective first-line option for achalasia treatment. However, the technical difficulty of POEM is high, and even in Japan, where endoscopic therapy is widespread, the procedure is limited to a small number of high-volume centers. Addressing expanding access to this effective technique is a significant future challenge. "
[Collapse]
Zhao CY, Xu N, Dong H, Chai NL, Linghu EQ. Effect of sex on the outcomes of peroral endoscopic myotomy for the treatment of achalasia. World J Gastroenterol 2025; 31(17): 104579
4
"The manuscript addresses the role of exosomal miR-137-3p derived from hypoxia-injured endometrial epithelial cells (EECDs) in ..."
[Read more]
"The manuscript addresses the role of exosomal miR-137-3p derived from hypoxia-injured endometrial epithelial cells (EECDs) in regulating hucMSC behavior, which is of potential interest in the context of endometrial regeneration. However, several critical issues limit the scientific clarity and integrity of the current work: In the first part of the results, the authors performed RNA sequencing to compare miRNA expression profiles in hucMSCs treated with EECD-ex versus EEC-ex. However, Figure 7 implies that the differential expression of miR-137-3p originates from differences in the exosomal content of EECD-ex versus EEC-ex. This is a fundamental inconsistency. Changes in miRNA expression within recipient hucMSCs do not directly reflect the cargo of the exosomes unless validated by exosome profiling. Such discrepancy may mislead the interpretation regarding the source and function of miR-137-3p. The manuscript does not provide essential data on the characterization of exosomes (e.g., TEM, NTA, exosomal markers such as CD63, CD81, or TSG101). Moreover, it is unclear whether there is a difference in exosome yield (i.e., production efficiency or protein content) between EEC-ex and EECD-ex. The manuscript lacks transparency on how miR-137-3p was selected from the pool of 53 differentially expressed miRNAs. While functional assays were performed on hucMSCs, the study does not include gain- or loss-of-function experiments at the exosomal level (e.g., using miR-137-3p inhibitors/mimics in donor EECs before exosome collection). Such experiments are critical to directly establish causality between EECD-exosomal miR-137-3p and the observed hucMSC behavior. "
[Collapse]
Zhang WY, Liu SM, Wang HB, Deng CY. Exosomal miR-137-3p targets UBE3C to activate STAT3, promoting migration and differentiation into endometrial epithelial cell of human umbilical cord mesenchymal stem cells under hypoxia. World J Stem Cells 2025; 17(4): 100359
5
"A letter to the Editor entitled Hypoxic endometrial epithelial cell-derived microRNAs effectively regulate the regenerative properties ..."
[Read more]
"A letter to the Editor entitled Hypoxic endometrial epithelial cell-derived microRNAs effectively regulate the regenerative properties of mesenchymal stromal cells by Dr Mallis elegantly comments on the significance of the study published by Dr Zhang. The author highlights the clinical significance of the data obtained from in vitro experiments and, at the same time, provides mechanistic insight into the role of mir-214-5p and 21-5p in mesenchymal stem cells’ functionality and reparability of endometrial endothelial cells. The author has rightfully suggested that the published data by Zhang et al. has been derived from in vitro experimentation and there is a need for supporting this data by in vivo experiments. The letter is fluently written and supplements the findings of Zhang et al. "
[Collapse]
Mallis P. Hypoxic endometrial epithelial cell-derived microRNAs effectively regulate the regenerative properties of mesenchymal stromal cells. World J Stem Cells 2025; 17(4): 102482
6
"Mubin Ozercan et al. presented an interesting article "Vonoprazan and proton pump inhibitors: Which is superior for Helicobacter ..."
[Read more]
"Mubin Ozercan et al. presented an interesting article "Vonoprazan and proton pump inhibitors: Which is superior for Helicobacter pylori eradication?" The authors' decision to summarize current information on the effectiveness of anti-Helicobacter therapy based on the use of proton pump inhibitors and based on the use of potassium-competing acid blockers(P-CAB) was absolutely correct and timely. A large number of comparative studies are available in scientific medical databases. Confirmation of the high level of effectiveness of potassium-competing acid blockers has practical significance for use in various eradication treatment regimens. "
[Collapse]
Ozercan M, Tawheed A, Ismail A, Amer MS, El-Kassas M. Vonoprazan and proton pump inhibitors: Which is superior for Helicobacter pylori eradication? World J Gastroenterol 2025; 31(17): 103156
7
"Title: Cardiac Metastatic Tumors: Revisiting Mechanisms and Future Perspectives To the Editor We read with great interest the article ..."
[Read more]
"Title: Cardiac Metastatic Tumors: Revisiting Mechanisms and Future Perspectives To the Editor We read with great interest the article by Luo et al.[1] titled "Comprehensive understanding of a rare disease: Cardiac metastatic tumor, a double-center 10-year case review," recently published in World Journal of Cardiology. We congratulate the authors for providing valuable clinical insights into the rare and underrecognized entity of cardiac metastatic tumors (CMTs). The study's finding that intracardiac metastases are associated with a poorer prognosis compared to pericardial involvement aligns with prior autopsy-based observations[2,3], emphasizing the prognostic importance of metastatic localization within the cardiac structure. The authors' inclusion of cardiac biomarkers, such as BNP and troponin, as predictors of adverse outcomes is particularly commendable and may represent a step toward more precise risk stratification. Building upon these important findings, we wish to highlight several emerging directions that could deepen our understanding of CMTs: First, organotropism and pre-metastatic niche formation are increasingly recognized as critical determinants of metastatic dissemination[4,5]. Experimental studies have demonstrated that cardiac tissue exhibits a unique extracellular matrix composition and a dynamic immunological environment, which may preferentially attract circulating tumor cells[6]. Investigating the role of cardiac-specific chemokine axes, such as CXCL12-CXCR4 signaling, may provide new insights into the molecular determinants of cardiac colonization. Second, advanced imaging modalities warrant greater emphasis in the diagnostic pathway. While echocardiography remains the first-line modality, cardiac magnetic resonance (CMR) imaging and ^18F-FDG PET-CT possess superior tissue characterization capabilities, enabling differentiation between malignant and benign cardiac masses with higher sensitivity and specificity[7,8]. Early integration of these modalities could significantly alter the therapeutic trajectory for patients with occult cardiac involvement. Third, therapeutic approaches for CMTs remain largely individualized and empirical. Although palliative strategies predominate, isolated reports suggest that surgical resection or stereotactic radiotherapy may improve quality of life and survival in carefully selected patients[9]. Prospective studies incorporating molecular tumor profiling—such as HER2, EGFR, or ALK status—may refine patient selection and therapeutic planning[10]. Moreover, given the rising incidence of CMTs in the era of improved oncological survival, it is imperative to establish multicenter registries and collaborative research networks focusing specifically on cardiac oncology. Standardizing diagnostic criteria, staging systems, and treatment algorithms would provide an urgently needed framework for evidence-based clinical decision-making. In conclusion, Luo et al. have made a valuable contribution by elucidating the clinical and prognostic characteristics of CMTs. Future investigations integrating molecular oncology, advanced imaging, and standardized therapeutic strategies will be pivotal to improving the outcomes of patients with this rare but increasingly encountered condition. References 1.Luo LY, Yang TS, He Z, Lin L, Luo XL. Comprehensive understanding of a rare disease: Cardiac metastatic tumor, a double-center 10-year case review. World J Cardiol. 2025;17(2):101851. doi:10.4330/wjc.v17.i2.101851 2.Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol. 2007;60(1):27-34. doi:10.1136/jcp.2005.035105 3.Lam KY, Dickens P, Chan AC. Tumors of the heart: a 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. 1993;117(10):1027-1031. 4.Peinado H, Zhang H, Matei IR, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17(5):302-317. doi:10.1038/nrc.2017.6 5.Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2012;2(12):1091-1099. doi:10.1158/2159-8290.CD-12-0329 6.Shinde AV, Frangogiannis NG. Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol. 2014;70:74-82. doi:10.1016/j.yjmcc.2013.12.011 7.Bogaert J, Francone M. Cardiac tumors and masses: the role of cardiovascular magnetic resonance imaging. Eur Radiol. 2009;19(1):14-27. doi:10.1007/s00330-008-1161-0 8.Rahbar K, Seifarth H, Schäfers M, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med. 2012;53(6):856-863. doi:10.2967/jnumed.111.099028 9.Yusuf SW, Bathina JD, Qureshi S, et al. Cardiac tumors in cancer patients: diagnosis, management, and prognosis. Oncologist. 2007;12(4):443-450. doi:10.1634/theoncologist.12-4-443 10.Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274-284. doi:10.1038/nrc2622 "
[Collapse]
Luo LY, Yang TS, He Z, Lin L, Luo XL. Comprehensive understanding of a rare disease: Cardiac metastatic tumor, a double-center 10-year case review. World J Cardiol 2025; 17(2): 101851
8
"The low-cost and easy-to-obtain characteristics of the TyG index introduced in this article make it feasible for clinical translation, ..."
[Read more]
"The low-cost and easy-to-obtain characteristics of the TyG index introduced in this article make it feasible for clinical translation, especially in resource-limited settings. However, the universality of the TyG index threshold is questionable, and the influence of metabolic characteristics (e.g., diet and genetics) in different populations needs to be considered. In addition, the role of TyG index in early gastric cancer and its relationship with the dynamic changes of tumor microenvironment have not been elucidated. It is worth noting that high TyG index may reflect enhanced metabolic reserve in advanced patients, while may promote malignant transformation in precancerous lesions, and this "double-edged sword" effect needs to be further explored. "
[Collapse]
Zhao CF, Liu XL, Wu NB, Xu ZF. Triglyceride-glucose index as a prognostic indicator in advanced gastric cancer: Insights and future research. World J Gastroenterol 2025; 31(17): 104794
9
"1、The study would be further strengthened if the authors could elaborate in greater detail on how STAT3 was identified and the ..."
[Read more]
"1、The study would be further strengthened if the authors could elaborate in greater detail on how STAT3 was identified and the specific mechanisms by which miR-137-3p regulates STAT3. 2、Frankly, the impact of miR-137-3p on p-STAT3 appears minimal, as shown in Figure 3B. 3、A more in-depth exploration of UBE3C’s role in modulating the STAT3 signaling pathway and its mechanistic underpinnings would enhance the study. For instance, investigating whether miR-137-3p influences STAT3 signaling following UBE3C knockdown could yield valuable insights. "
[Collapse]
Zhang WY, Liu SM, Wang HB, Deng CY. Exosomal miR-137-3p targets UBE3C to activate STAT3, promoting migration and differentiation into endometrial epithelial cell of human umbilical cord mesenchymal stem cells under hypoxia. World J Stem Cells 2025; 17(4): 100359
10
"comment to Rhapontin activates nuclear factor erythroid 2-related factor 2 to ameliorate ..."
[Read more]
"comment to Rhapontin activates nuclear factor erythroid 2-related factor 2 to ameliorate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced gastrointestinal dysfunction in Parkinson's disease mice We are delighted to have read the article titled "Rhapontin activates nuclear factor erythroid 2-related factor 2 to ameliorate 1-methyl-4-phenyl-1,2,3,6-tetrahydr- opyridine-induced gastrointestinal dysfunction in Parkinson's disease mice" authored by Xin-Yu Wang’s team in the World Journal of Gastroenterology. Parkinson’s disease (PD) is a multicentric neurodegenerative disorder characterized by the accumulation and aggregation of alfa-synuclein (α-syn) in the substantia nigra in the central nervous system (CNS) and in other neural structures(1). It is the second most common and the most rapidly rising neurodegenerative disease in the world(2). While the exact causes behind the increasing incidence and prevalence of PD remain unclear, contributing factors may include longer life expectancy, declining smoking rates, and exposure to environmental pollutants and toxins(3). Among the earliest manifestations of PD are gastrointestinal (GI) symptoms, which often precede the onset of motor impairments. GI dysfunction in PD is closely linked to the gut-brain axis, reflecting the bidirectional communication between the CNS and the GI tract in both health and disease (4). However, there are still limitations in the research on the relationship between PD and GI dysfunction, and the specific molecular mechanism has not been fully elucidated. In this study, the findings of Xin-Yu Wang’s team provide valuable insights and innovative approaches for PD treatment. This paper represents the first systematic demonstration that rhapontin alleviates gut-brain axis dysfunction in PD by activating colonic NRF2, thereby offering a novel therapeutic target for the disease. By integrating network pharmacology predictions with experimental validation, this study enhances its scientific robustness and credibility. Furthermore, a key discovery of this study is that the anti-inflammatory effects of rhapontin are predominantly localized to the intestinal tract rather than being mediated through the brain-derived NRF2 pathway. This provides experimental evidence supporting the "enteric pathology hypothesis" of PD (5). Overall, these findings present critical theoretical support for rhapontin as a promising therapeutic agent for GI dysfunction in PD. However, we have several exploratory comments regarding certain aspects of the study. First, extensive research has established the critical role of the gut-brain axis in mediating GI dysfunction associated with PD through interconnected pathophysiological mechanisms. For example, gut microbiota dysbiosis can compromise intestinal barrier integrity, leading to a "leaky gut" phenomenon. This allows lipopolysaccharides (LPS) to trigger immune cell activation and the release of pro-inflammatory cytokines, which contribute to systemic inflammation and increased blood-brain barrier (BBB) permeability. Consequently, peripheral inflammatory signals can spread to the CNS, and after that, pathological α-syn will aggregate in the dorsal motor nucleus of the vagus nerve (DMV) and the substantia nigra. The levels of pathological α-syn also increase mitochondrial fragmentation in the DMV, ultimately leading to PD pathophysiology (6). Pathogenic α-syn may spread from the gut to the brain, leading to the degeneration of the nigrostriatal dopaminergic system, thus increasing the risk of developing PD (7, 8). Supporting this, animal studies have shown that fecal microbiota transplantation from PD patients induces α-syn aggregation and dopaminergic neuron loss (9). Additionally, gut microbiota also can regulate neurotransmitter homeostasis by modulating dopamine (DA) and serotonin production, while short-chain fatty acids (SCFAs) help mitigate intestinal inflammation, reduce oxidative stress, and enhance BBB integrity to protect DA neurons(6, 10-12). One of the characteristics of PD is the progressive loss of DA neurons in the substantia nigra pars compacta (13). Lastly, dysbiotic gut microbiome (dysbiome) can impair mitochondrial energy metabolism, trigger the TLR4/NF-κB pathway, and exacerbate oxidative stress, ultimately leading to the degeneration of nigral dopaminergic neurons (6). Collectively, these mechanisms form a core network through which the gut-brain axis contributes to PD pathogenesis. In this study, only studied the effect between rhapontin and the gastrointestinal dysfunction caused by PD, without systematically combining the gut-brain axis with PD for research. Additionally, although gut microbiota play a pivotal role in the gut-brain axis of PD, the study does not evaluate the influence of rhapontin on microbiota composition or function (14-16). It remains unclear whether rhapontin indirectly activates NRF2 or reduces inflammation by modulating specific microbial populations. Future studies could explore this by employing approaches such as 16S rRNA sequencing or metagenomics to assess changes in fecal microbiota composition, alongside quantifying microbiota-derived metabolites. Such investigations would provide deeper insights into the gut-brain axis dynamics and further elucidate rhapontin’s mechanisms of action. Secondly, rhapontin is a stilbenoid glucoside compound, found in medicinal plant of rhubarb rhizomes. Research into the anti-inflammatory mechanisms of rhapontin has revealed its multi-pathway synergistic effects. For example, in LPS-induced endothelial cell inflammation models, rhapontin effectively suppresses nitric oxide (NO) and TNF-α production while downregulating the expression of Inducible Nitric Oxide Synthase (iNOS), Cyclooxygenase-2 (COX-2), and NADPH Oxidase - related genes (NOX-related genes). These effects are primarily achieved by inhibiting the activation of key proteins in the Nuclear Factor-kappa B (NF-κB) and Mitogen - Activated Protein Kinase (MAPK) signaling pathways(17). In terms of antioxidant regulation, rhapontin activates the NRF2 signaling pathway, which reduces Tumor Necrosis Factor-alpha (TNF-α) and Matrix Metalloproteinase-2 (MMP-2) levels in diabetic retinopathy models, while enhancing the expression of Interleukin – 10 (IL-10) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) and inhibiting NF-κB nuclear translocation(18). Its anti-fibrotic properties are mediated through dual mechanisms: activating Adenosine Monophosphate - Activated Protein Kinase (AMPK) and inhibiting the Transforming Growth Factor – beta (TGF-β)/Smad pathway, which helps reverse abnormal extracellular matrix deposition and prevents the progression of pulmonary fibrosis(19). Additionally, rhapontin has been shown to improve colonic epithelial barrier function via Sirtuin 1 (SIRT1) signaling activation(20). Together, these findings systematically highlight rhapontin's integrative therapeutic effects through coordinated modulation of NF-κB/MAPK, AMPK/TGF-β/Smad, and SIRT1 signaling networks, addressing inflammation, oxidative stress, and fibrosis. The current study demonstrated that rhapontin effectively reduces inflammation by decreasing the levels of pro-inflammatory cytokines, including IL-6, TNF-α, and IL-1β, while also activating the NRF2 signaling pathway to improve gastrointestinal function. However, the study did not explore rhapontin's potential role in preventing the progression of pulmonary fibrosis through AMPK activation and inhibition of the TGF-β/Smad pathway, nor did it investigate its effects on improving colonic epithelial barrier function via activation of the SIRT1 signaling pathway. Additionally, while network pharmacology was used to predict shared targets between PD and rhapontin, and the top 10 key targets were identified using a protein-protein interaction (PPI) network, the relationship between these targets and NRF2 remains poorly defined. Moreover, the study lacks detailed mechanistic insights into the specific signaling pathways associated with NRF2, including its upstream and downstream regulatory mechanisms—an area that requires further investigation. The article also does not clearly explain how NRF2 was identified as a key target. o address these research gaps, future studies could employ techniques such as Western blotting (WB) and co-immunoprecipitation (Co-IP) to validate the protein-protein interactions between rhapontin's potential targets and NRF2. Additionally, methods such as quantitative real-time polymerase chain reaction (qPCR) or RNA sequencing could be used to analyze downstream gene expression regulated by NRF2. These approaches would provide a more comprehensive understanding of the molecular mechanisms underlying rhapontin's anti-inflammatory effects, offering deeper insights into its therapeutic potential for PD. In evaluating the experimental section of this study, some points warrant further discussion. First, regarding the presentation of the results: Figure 2A does not clearly label which specific experimental group each result corresponds to, making interpretation challenging. Additionally, the WB image in Figure 5A lacks clarity and does not exhibit an obvious trend in the results, which may hinder the ability to draw definitive conclusions. Second, concerning the experimental methods: the study utilized only two approaches—the open field test and the pole-climbing test—to assess the motor abilities of mice. While these methods provide useful insight, they may be insufficient for a comprehensive evaluation of motor behavior in PD. Incorporating additional behavioral experiments, such as the Morris water maze, eight-arm radial maze, and elevated plus maze, could allow for a more thorough assessment of motor and cognitive functions in the mouse model (21). In summary, Wang XY’s team has conducted pioneering research, offering significant insights into the therapeutic potential of rhapontin for GI dysfunction in PD. This work is highly commendable, and we look forward to the authors addressing the aforementioned concerns in future studies through more detailed experimental design and exploration. Such efforts would further enhance the robustness and comprehensiveness of their findings. 1. Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW Neuropathology and molecular diagnosis of Synucleinopathies. Mol Neurodegener. 2021;16(1):83. 2. delete Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939-53. 3. Bloem BR, Okun MS, Klein C Parkinson's disease. Lancet. 2021;397(10291):2284-303. 4. Gao V, Crawford CV, Burré J The Gut-Brain Axis in Parkinson's Disease. Cold Spring Harb Perspect Med. 2025;15(1). 5. Safarpour D, Sharzehi K, Pfeiffer RF Gastrointestinal Dysfunction in Parkinson's Disease. Drugs. 2022;82(2):169-97. 6. Munoz-Pinto MF, Candeias E, Melo-Marques I, Esteves AR, Maranha A, Magalhães JD, Carneiro DR, Sant'Anna M, Pereira-Santos AR, Abreu AE, Nunes-Costa D, Alarico S, Tiago I, Morgadinho A, Lemos J, Figueiredo PN, Januário C, Empadinhas N, Cardoso SM Gut-first Parkinson's disease is encoded by gut dysbiome. Mol Neurodegener. 2024;19(1):78. 7. Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease. Neuron. 2019;103(4):627-41.e7. 8. Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, Tsung-Pin P, Riess O, Nyengaard JR, Tamgüney G, Jensen PH, Borghammer P Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol. 2019;138(4):535-50. 9. Tan AH, Lim SY, Lang AE The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol. 2022;18(8):476-95. 10. Du J, Zhang P, Tan Y, Gao C, Liu J, Huang M, Li H, Shen X, Huang P, Chen S Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD). Mov Disord. 2024;39(8):1397-402. 11. Nishiwaki H, Hamaguchi T, Ito M, Ishida T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder. mSystems. 2020;5(6). 12. Wang Q, Luo Y, Ray Chaudhuri K, Reynolds R, Tan EK, Pettersson S The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options. Brain. 2021;144(9):2571-93. 13. Tolosa E, Garrido A, Scholz SW, Poewe W Challenges in the diagnosis of Parkinson's disease. Lancet Neurol. 2021;20(5):385-97. 14. Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 2016;167(6):1469-80.e12. 15. Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome. 2021;9(1):226. 16. Metta V, Leta V, Mrudula KR, Prashanth LK, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. J Neurol. 2022;269(3):1154-63. 17. Li R, Chinnathambi A, Alharbi SA, Shair OHM, Veeraraghavan VP, Surapaneni KM, Rengarajan T Anti-inflammatory effects of rhaponticin on LPS-induced human endothelial cells through inhibition of MAPK/NF-κβ signaling pathways. J Biochem Mol Toxicol. 2021;35(5):e22733. 18. Shi Q, Cheng Y, Dong X, Zhang M, Pei C, Zhang M Effects of rhaponticin on retinal oxidative stress and inflammation in diabetes through NRF2/HO-1/NF-κB signalling. J Biochem Mol Toxicol. 2020;34(11):e22568. 19. Tao L, Cao J, Wei W, Xie H, Zhang M, Zhang C Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo. Int Immunopharmacol. 2017;47:38-46. 20. Wei W, Wang L, Zhou K, Xie H, Zhang M, Zhang C Rhapontin ameliorates colonic epithelial dysfunction in experimental colitis through SIRT1 signaling. Int Immunopharmacol. 2017;42:185-94. 21. Tuersong T, Wu QF, Chen Y, Shan Li P, Yong YX, Shataer M, Shataer S, Ma LY, Yang XL Integrated network pharmacology, metabolomics, and microbiome studies to reveal the therapeutic effects of Anacyclus pyrethrum in PD-MCI mice. Phytomedicine. 2025;142:156729. "
[Collapse]
Wang XY, Liu F, Wang QT, Li SZ, Ye YZ, Chen T, Cai BC. Rhapontin activates nuclear factor erythroid 2-related factor 2 to ameliorate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced gastrointestinal dysfunction in Parkinson's disease mice. World J Gastroenterol 2025; 31(15): 104875
11
"Name of Journal:World Journal of Hepatology Manuscript NO: Manuscript Type: LETTER TO THE EDITOR Commentary: Multi-omics reveals the ..."
[Read more]
"Name of Journal:World Journal of Hepatology Manuscript NO: Manuscript Type: LETTER TO THE EDITOR Commentary: Multi-omics reveals the associations among the fecal metabolome,intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma Biao Wen,Yin-Ping Wang Biao Wen,Yin-Ping Wang,Department of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610000, Sichuan Province, China Author contributions:Yin-Ping Wang wrote the original draft; Biao Wen contributed to conceptualization, writing, reviewing and editing; Yin-Ping Wang and Biao Wen participated in drafting the manuscript; and all authors have read and approved the final version of the manuscript. Supported by ORCID number：0000-0001-5226-5981 Corresponding author:Biao Wen,MD, PhD,Assistant Professor,Department of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College,No. 312, Middle Section of Baoguang Avenue, Xindu District, Chengdu 610000, Sichuan Province, China. 820695761@qq.com Received: Revised: Accepted: Published online: Abstract: Recently, Feng J et al. published an important study. The research team revealed the associations of fecal metabolomics, intestinal bacteria and serum indicators in patients with hepatocellular carcinoma (HCC) through multi-omics analysis. The research results indicate that the composition of the metabolome and intestinal bacteria in fecal samples is expected to become a potential biomarker for the diagnosis of HCC. After a thorough review of their work, we put forward two insights regarding the impact of hepatitis B virus and antiviral drugs on the intestinal flora of HCC, the changes in intestinal microbiota in HCC and healthy control groups. Key Words: Liver neoplasms; Gastrointestinal microbiome; Antiviral drug; Comment; Core Tip: We conducted a rigorous assessment of the research by Feng et al., and put forward expert suggestions regarding the changes of HCC in the gut microbiota and the impact of hepatitis B virus and related antiviral drugs on the microbiota, in order to advance this scientific field. TO THE EDITOR After reading the study titled "Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma" by Feng et al. published in the World Journal of Gastroenterology, we found it highly insightful. The authors employed integrated metabolomic and microbiomic approaches to elucidate the linkages between fecal metabolites, gut microbiota, and serum biomarkers in hepatocellular carcinoma (HCC) patients, providing new perspectives for the early diagnosis of HCC. Here, we would like to share our perspectives on the following aspects: The impact of hepatitis B virus (HBV) and antiviral therapies on gut microbiota alterations in HCC; Gut microbial differences between HCC patients and healthy controls. The first point: The changes in the gut microbiota of HCC and healthy control groups vary in different studies and may be influenced by multiple factors More and more studies have shown that the intestinal microbiota is related to the occurrence of HCC and is expected to become a biomarker for the diagnosis of HCC. In the study by Feng et al., it was concluded that Lachnospira, Streptococcus and Veillonella are representative differential bacterial genera in the feces of HCC patients. These three bacterial genera and their related metabolites may serve as unique biomarkers [1]. Most studies have shown that there are differences in theα-diversity orβ-diversity of the intestinal microbiota between HCC patients and healthy control groups. However, these differences may vary when further studying the intestinal microbiota of HCC patients, such as at the genus level or species level. Zhang et al. found that Enterococcaceae, Lactobacillus, Bacillus and Gammaproteobacteria can be used as diagnostic markers for primary liver cancer (PLC). In addition, a correlation analysis was conducted, and the results showed that Veillonella was significantly positively correlated with alpha-fetoprotein (AFP) in PLC patients[2]. In 2023, Zhang et al. demonstrated that at the family level, the abundance of Lachnospiraceae, Coriobacteriaceae, Eggerthellaceae and Synergistaceae in the liver cancer group was significantly reduced compared with the normal group. The abundances of Enterobacteriaceae, Fusobacteriaceae, Lactobacillus and Erysierysiaceae increased significantly. At the horizontal level, compared with the normal group, The liver cancer groups included Blautia, Fusicatenibacter, Anaerostipes, Lachnospiraceae_ND3007_group, GG-56, Eggerthella, Lachnospiraceae_FCS020_group and The abundance of Olsenella was significantly reduced. The abundance of Escherichia coli - Shigella, Prevotella_2 Tyzzerella_4, Clostridium erysipelum and Prevotella_2 Tyzzerella ₄ increased significantly. Meanwhile, alpha-fetoprotein (AFP) is positively correlated with the abundance of Streptococcus[3];Yang et al. confirmed through a prospective study that in terms of intestinal samples, the average relative abundance of Proteobacteria in the HCC group was significantly higher than that in the control group. The abundance of Streptococcus in oral and fecal samples of HCC patients was higher than that in the control group. Meanwhile, during the transition from a healthy state to liver cirrhosis and HCC, the content of streptococcus in the hepatocellular carcinoma and liver cirrhosis groups was much higher than that in the control group, and showed an upward trend during the disease progression. From the analysis of microbial correlations and clinical characteristics and functions among each group, both Streptococcus and Virongella were identified in the microbial communities of oral and intestinal samples, and both were in key positions in the microbial correlation network of fecal samples. Streptococcus and Virongella showed a consistent trend. Among them, the microbiome distribution was positively correlated with MELD, Child-Pugh, age, CCI, AFP, AST, ALT, GGT, Cre, LDL, Tchol, PT and INR, and negatively correlated with ALB, BMI, HDL, TG and PLT in HCC patients. This study has similarities with that of Feng J et al[4];In 2024, the research results of Jinato et al. indicated that HCC was enriched with five genera, including Bacteroides, Streptococcus, Ruminococcus, Veronistella and Clostridium erysibiricum. And Romboutsia, UCG-002, Lachnospiraceae NK4A-136, Eubacterium hallii group, Lachnospiraceae ND-3007 group, Erysipelotrichaceae Seven genera such as UCG-003 and Bilophila have low abundance in HCC patients[5]. From the above, it can be known that some studies have mentioned the three bacterial genera, Streptococcus, Veronella, and Lachnospira, in the HCC and healthy groups, showing an increase in the abundance of Streptococcus and Veronella, while the relative abundance of Lachnospira has decreased. However, in different studies, The reasons for the incomplete similarity in the abundance and structure of the intestinal microbiota between HCC and the healthy control group may be related to the drug use, alcohol consumption, diet, racial and regional differences of HCC patients[6];A Western diet high in fat, cholesterol or sugar can induce dysbiosis of the gut microbiome, a reduction in symbiotic probiotics and an increase in opportunistic pathogens[7];For example, the formation of NAFLD-HCC induced by dietary cholesterol is related to intestinal flora imbalance, and the composition of the microbiota changes with the formation stage of NAFLD-HCC: Mucispirillum, Desulfovibrio, Anaerotruncus and Desulfovibrionaceae increased successively; Bifidobacterium and Bacteroides were depleted in mice fed with HFHC, which was also confirmed in patients with human hypercholesterolemia[8].Therefore, it is still necessary to further verify the unique biomarkers of HCC. The second point: Distinguish the independent effects of HBV infection and HCC and include data on the use of antiviral drugs Hepatitis B virus infection can directly disrupt the intestinal flora balance through systemic inflammatory responses and disorders of the hepatoenteric axis. The study by Shen et al. indicated that the flora composition of patients with HBV-CLD (such as enrichment of Streptococcus and reduction of Bifidobacterium) was significantly different from that of the healthy control group. It is suggested that HBV infection itself has unique microbiota characteristics; Meanwhile, antiviral drug treatment can partially reverse the dysbiosis caused by HBV[9-10]; Jinato et al. studied the changes in the gut microbiota between Viral (virus-HCC) and non-viral (NNC-HCC) -related hepatocellular carcinomas and found that compared with virus-HCC, the NNC-HCC subgroup significantly reduced various bacteria that produce short-chain fatty acids and the reduction of fecal butyrate[5];Liu et al. also analyzed the intestinal microbiota changes in hepatitis B virus-associated hepatocellular carcinoma. The research results showed that there were differences in the abundance of bacteria in the intestines of patients with B-HCC and NNBNC-HCC, and these bacteria were respectively involved in different functions or biological pathways[11]. Therefore, whether there is HBV infection and whether antiviral treatment is used may have an impact on the changes in the intestinal flora. In the study by Feng J et al., we found that HBV accounted for a high proportion (78.95%) in the HCC population. Based on previous studies, stratified comparison of HCC patients with HBV(+) and HBV(-), as well as recording the use of antiviral drugs and analyzing their effects, can more accurately clarify the microbiota characteristics of HCC itself. All in all, the changes in the gut microbiota are related to the occurrence and development of HCC. The inconsistency in the research on the gut microbiota related to HCC reflects the complexity of the disease and the dynamics of host-microbiota interactions. Future studies need to directly compare the microbiota, metabolome and immune characteristics of patients with HBV(+)HCC and HBV(-)HCC through larger sample cohorts of HCC, and combine animal models to verify the causal mechanism in order to reveal more robust microbiota characteristics and their mechanism of action in the occurrence and development of HCC. We look forward to the author team conducting follow-up research in this direction and promoting the innovation of early diagnosis techniques for HCC. Once again, we thank the authors for their outstanding work, which has opened up new ideas for HCC research. Conflict-of-interest statement: No potential conflicts of interest relevant to this article were reported. 1.Feng J, Wang J P, Hu J R, et al. Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma[J]. World Journal of Gastroenterology, 2025, 31(15). 2.Zhang L, Wu YN, Chen T, Ren CH, Li X, Liu GX. Relationship between intestinal microbial dysbiosis and primary liver cancer. Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):149-157. doi: 10.1016/j.hbpd.2019.01.002. Epub 2019 Jan 4. PMID: 30661942. 3.Zhang W, Xu X, Cai L, Cai X. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma. Sci Rep. 2023 May 13;13(1):7797. doi: 10.1038/s41598-023-34765-w. PMID: 37179446; PMCID: PMC10182990. 4.Yang J, He Q, Lu F, Chen K, Ni Z, Wang H, Zhou C, Zhang Y, Chen B, Bo Z, Li J, Yu H, Wang Y, Chen G. A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma. Gut Microbes. 2023 Jan-Dec;15(1):2201159. doi: 10.1080/19490976.2023.2201159. PMID: 37089022; PMCID: PMC10128432. 5.Jinato T, Anuntakarun S, Satthawiwat N, Chuaypen N, Tangkijvanich P. Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma. Appl Microbiol Biotechnol. 2024 Dec;108(1):34. doi: 10.1007/s00253-023-12845-1. Epub 2024 Jan 6. PMID: 38183473; PMCID: PMC10771587. 6.Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020 Jul;159(1):335-349.e15. doi: 10.1053/j.gastro.2020.02.068. Epub 2020 Apr 2. PMID: 32247694; PMCID: PMC8630546. 7.Pan Y, Zhang X. Diet and gut microbiome in fatty liver and its associated liver cancer. J Gastroenterol Hepatol. 2022 Jan;37(1):7-14. doi: 10.1111/jgh.15713. Epub 2021 Nov 3. PMID: 34664301. 8.Zhang X, Coker OO, Chu ES, Fu K, Lau HCH, Wang YX, Chan AWH, Wei H, Yang X, Sung JJY, Yu J. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut. 2021 Apr;70(4):761-774. doi: 10.1136/gutjnl-2019-319664. Epub 2020 Jul 21. PMID: 32694178; PMCID: PMC7948195. 9.Shen Y, Wu SD, Chen Y, Li XY, Zhu Q, Nakayama K, Zhang WQ, Weng CZ, Zhang J, Wang HK, Wu J, Jiang W. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. Gut Microbes. 2023 Jan-Dec;15(1):2155018. doi: 10.1080/19490976.2022.2155018. PMID: 36519342; PMCID: PMC9757487. 10.Li YG, Yu ZJ, Li A, Ren ZG. Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions. World J Gastroenterol. 2022 Jul 28;28(28):3555-3572. doi: 10.3748/wjg.v28.i28.3555. PMID: 36161048; PMCID: PMC9372803. 11.Liu Q, Li F, Zhuang Y, Xu J, Wang J, Mao X, Zhang Y, Liu X. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma. Gut Pathog. 2019 Jan 18;11:1. doi: 10.1186/s13099-018-0281-6. PMID: 30675188; PMCID: PMC6337822. "
[Collapse]
Feng J, Wang JP, Hu JR, Li P, Lv P, He HC, Cheng XW, Cao Z, Han JJ, Wang Q, Su Q, Liu LX. Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma. World J Gastroenterol 2025; 31(15): 104996
12
"The author has provided an interesting study to associate between Epstein-Barr virus and ulcerative colitis with surgery or not. ..."
[Read more]
"The author has provided an interesting study to associate between Epstein-Barr virus and ulcerative colitis with surgery or not. Meanwhile, the similar virus of Cytomegalovirus also presented a high level in this investigation as data indicated in this study. Maybe author can perform a demonstration to clarify the more connection between the two distinct groups of herpes simplex virus in the development of ulcerative colitis. "
[Collapse]
Zhang H, Gu X, He W, Zhao SL, Cao ZJ. Epstein-Barr virus infection is an independent risk factor for surgery in patients with moderate-to-severe ulcerative colitis. World J Gastroenterol 2025; 31(16): 104758
13
"The manuscript 'MicroRNA-155 modulation by renin-angiotensin system inhibitors may underlie their enigmatic role in COVID-19' by ..."
[Read more]
"The manuscript 'MicroRNA-155 modulation by renin-angiotensin system inhibitors may underlie their enigmatic role in COVID-19' by Konstantinos I Papadopoulos, Alexandra Papadopoulou and Tar Choon Aw addresses the problem of personalized therapy of COVID-19. The authors rightly point out that agents that inhibit the activity of the renin-angiotensin system (RAS), such as angiotensin-converting enzyme inhibitors and AT1R antagonists, can have opposite effects from protective to harmful on the course of the disease, and that worsening of symptoms is seen predominantly in the elderly, in patients with type 2 diabetes, cardiovascular and renal disease, and in some other comorbidities. The authors hypothesise that the negative effects of inhibitors of RAS activity are due to their induced dysregulation of erythropoietin secretion and decreased miRNA-155 levels. The paper cites two references to studies that found a decrease in miRNA-155 following exposure to RAS inhibitors. In conclusion, it is suggested that mineralocorticosteroid receptor antagonists and L-type calcium channel blockers may be preferable to RAS inhibitors in elderly patients and in some comorbidities characterised by reduced baseline miRNA-155 levels. However, a number of the points made by the authors need to be thoroughly tested in further studies, as there is evidence of increased miRNA-155 levels in COVID-19 patients (Asadpour-Behzadi et al, 2023, Haroun et al, 2022), reduced severity of cytokine storm in miRNA-155 knockout animals (Soni et al, 2025) and positive correlation of miRNA-155 levels with inflammatory markers in COVID-19 patients (AL-Nuaimi AL-azzawi, 2025). However, these data do not exclude the possibility that optimal elevation of miRNA-155 levels may be protective, as has been shown in patients with coronary artery disease (Zhu et al., 2014, Ban et al., 2023). Given that miRNA-155 regulates the activity of more than 200 genes, such a non-linear dependence of its effects on levels and physiological characteristics of the organism seems legitimate. The article thus raises a pressing issue that will undoubtedly require further research. "
[Collapse]
Papadopoulos KI, Papadopoulou A, Aw TC. MicroRNA-155 modulation by renin-angiotensin system inhibitors may underlie their enigmatic role in COVID-19. World J Exp Med 2025; 15(2): 100748
14
"1. Title ✅ Yes – The title accurately reflects the manuscript’s focus on the discrepancies between diagnostic modalities and ..."
[Read more]
"1. Title ✅ Yes – The title accurately reflects the manuscript’s focus on the discrepancies between diagnostic modalities and histopathologic assessment in Crohn’s disease (CD). It clearly conveys the study’s central theme. 2. Abstract ✅ Yes – The abstract provides a concise yet comprehensive summary of the manuscript’s objectives, key findings, and conclusions. It effectively outlines the challenges in assessing CD and the importance of multimodal evaluation. 3. Key Words ✅ Yes – The selected keywords (Crohn’s disease, transmural inflammation, histopathological scoring system, endoscopy, cross-sectional imaging techniques) are well-chosen and align with the manuscript’s focus. 4. Background ✅ Yes – The introduction thoroughly discusses the current understanding of CD, its transmural nature, and the limitations of existing diagnostic methods. It establishes a strong rationale for the study. 5. Methods ⚠️ No – Since this is a narrative review, the manuscript lacks explicit methodological details (e.g., search strategy, inclusion/exclusion criteria). A more structured approach (e.g., PRISMA guidelines) would strengthen its rigor. 6. Results ✅ Yes – The review successfully synthesizes current evidence on diagnostic discrepancies in CD, highlighting gaps and emerging technologies (e.g., AI, advanced imaging). ✅ Yes – The study contributes meaningfully to the field by emphasizing the need for standardized histologic and imaging assessments in CD management. 7. Discussion ✅ Yes – The discussion logically interprets findings, underscoring the clinical implications of discordant diagnostic modalities. Key points (e.g., transmural healing as a treatment goal) are well-articulated. ✅ Yes – The applicability of findings to clinical practice and research is clearly stated, with actionable insights (e.g., optimizing biopsy protocols). ✅ Yes – The discussion is scientifically sound, balancing technical details (e.g., imaging techniques) with broader relevance to gastroenterology. 8. Illustrations and Tables ❌ No – The manuscript would benefit from visual aids (e.g., tables comparing scoring systems, imaging modalities; diagrams of transmural inflammation). ❌ No – If figures were included, clearer labeling (e.g., arrows for histologic features) would enhance interpretability. 9. Biostatistics 🔘 N/A – Not applicable, as this is a narrative review without original data analysis. 10. Units ✅ Yes – SI units (e.g., mm for wall thickness) are used correctly and consistently. 11. References ✅ Yes – References are up-to-date (including 2024–2025 publications) and authoritative, covering clinical, endoscopic, and histologic aspects of CD. ❌ No – No excessive self-citation or omission of key literature is evident. 12. Quality of Manuscript Organization and Presentation ✅ Yes – The manuscript is well-structured, with a logical flow from background to discussion. Subheadings improve readability. ✅ Yes – Language and grammar are precise, with only minor edits needed (e.g., occasional redundancy in phrasing). 13. Ethics Statements 🔘 N/A – No human/animal studies were conducted; ethics approval is not required. Overall Evaluation Scientific Quality: Grade B (Very Good) Strengths: Comprehensive literature synthesis, clear clinical relevance, and balanced discussion of diagnostic challenges. Areas for Improvement: Include methodological details for transparency (e.g., how studies were selected). Add tables/figures to summarize complex concepts (e.g., imaging vs. histologic criteria). Language Quality: Grade A (Excellent) The writing is polished, with minimal grammatical errors and effective use of technical terminology. Suggestions for Authors Enhance Methodology: Briefly describe the review’s approach (e.g., database search terms, timeframe) to bolster reproducibility. Add Visual Summaries: A table comparing histologic scoring systems or imaging modalities would aid reader comprehension. Clarify Clinical Takeaways: Consider a bullet-point summary of key recommendations for clinicians (e.g., when to use EUS vs. MRE). This review provides valuable insights into CD diagnostics and would be further strengthened by these refinements. "
[Collapse]
Fang HM. Intricacy of Crohn’s disease: Incongruity between diagnostic modalities and histopathologic assessment. World J Gastrointest Endosc 2025; 17(4): 103979
15
"Bleeding is a significant complication of acute-on-chronic liver failure (ACLF), with prolonged prothrombin time and thrombocytopenia ..."
[Read more]
"Bleeding is a significant complication of acute-on-chronic liver failure (ACLF), with prolonged prothrombin time and thrombocytopenia in these patients elevating the perceived risk of bleeding. We were intrigued by the manuscript by Liu et al. [1], which investigates the efficacy and safety of recombinant human thrombopoietin (rhTPO) in treating thrombocytopenia among ACLF patients. This prospective, open-label study involved 70 ACLF patients with severe thrombocytopenia, who were assigned to either an rhTPO group or a control group. The primary endpoint was the proportion of patients achieving a platelet count greater than 50 × 10^9/L by day 14. The study’s noteworthy findings indicated that rhTPO significantly increased platelet counts in ACLF patients, with a higher proportion reaching the target platelet count in the rhTPO group compared to the control group (60.7% vs. 12.0%). The study concluded that rhTPO effectively elevates platelet counts, improves liver function, and reduces bleeding events in ACLF patients with thrombocytopenia, while maintaining a favorable safety profile. These findings provide promising insights into managing thrombocytopenia in ACLF patients. While this study holds clinical significance, it also has notable limitations. Liver disease has long been recognized as a condition associated with bleeding disorders, which arise from multiple factors [2,3]. These include thrombocytopenia, low levels of coagulation factors, and decreased fibrinolytic proteins, all contributing to the coagulopathy seen in liver disease [4]. Thrombocytopenia is one of the most common hematological abnormalities and often the first abnormality detected in chronic liver disease patients [5]. While mild to moderate thrombocytopenia rarely has clinical significance due to the low likelihood of spontaneous bleeding, moderate to severe thrombocytopenia can hinder patients from receiving essential interventions, including medications and invasive procedures. Delays in procedures and the need to correct platelet abnormalities can extend hospital stays and increase overall healthcare costs [6,7]. Increasing platelet counts and achieving rebalanced hemostasis appears to be a strategy for controlling the risk of acute bleeding in ACLF patients without raising the risk of thrombosis; however, the impact on disease prognosis requires further investigation [2]. Despite indicating that increasing platelet counts and achieving rebalanced hemostasis may help control the risk of acute bleeding in ACLF patients without increasing the risk of thrombosis, further investigation is necessary to understand the impact on disease prognosis. Additionally, while serum hepatocyte growth factor and thrombopoietin (TPO) levels were measured, key coagulation-related tests were not further explored. Simply correcting thrombocytopenia does not address all facets of coagulation [8]. Furthermore, laboratory tests such as platelet aggregation and thromboelastography were not conducted. These assessments could provide a more comprehensive understanding of the extent to which the coagulopathy in ACLF patients has been addressed, rather than relying solely on platelet counts [9]. Moreover, the study's small sample size limits its statistical power and may introduce confounding factors. The analysis of results was relatively straightforward and did not adequately account for potential confounders. Consequently, the conclusions drawn should be considered preliminary. The exploratory and pilot nature of this study limits its clinical significance. Nonetheless, it remains a valuable contribution to the field, providing direction for future research and establishing a foundational basis for subsequent investigations. Currently, in addition to rhTPO, there are other treatment options available, such as oral small molecule agonists of TPO receptor like avatrombopag [10]. Further studies comparing these agents are needed to determine the optimal strategies for managing bleeding risk in ACLF patients. Overall, this research offers hope for the management of ACLF patients and points toward future investigation directions. REFERENCES 1. Liu G, Tang F, Wang T, Yan JQ, Li FH, Ha FS, Zhang X, Jing L, Liang J. Efficacy of recombinant human thrombopoietin in patients with acute-on-chronic liver failure and thrombocytopenia: A prospective, open-label study. World J Gastroenterol. 2025;31 14:105004. doi: 10.3748/wjg.v31.i14.105004. 2. Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases. Res Pract Thromb Haemost. 2017;1 2:150-161. doi: 10.1002/rth2.12028. 3. Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37 2:280-7. doi: 10.1016/s0168-8278(02)00199-x. 4. Stravitz RT, Ellerbe C, Durkalski V, Schilsky M, Fontana RJ, Peterseim C, Lee WM; Acute Liver Failure Study Group. Bleeding complications in acute liver failure. Hepatology. 2018;67 5:1931-1942. doi: 10.1002/hep.29694. 5. Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol. 2011;55 6:1415-27. doi: 10.1016/j.jhep.2011.06.008. 6. Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther. 2007;26 Suppl 1:5-11. doi: 10.1111/j.1365-2036.2007.03510.x. 7. Moore AH. Thrombocytopenia in Cirrhosis: A Review of Pathophysiology and Management Options. Clin Liver Dis (Hoboken). 2019;14 5:183-186. doi: 10.1002/cld.860. 8. O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology. 2019;157 1:34-43.e1. doi: 10.1053/j.gastro.2019.03.070. 9. Biswas S, Anand A, Vaishnav M, Mehta S, Swaroop S, Aggarwal A, Arora U, Agarwal A, Elhence A, Mahapatra SJ, Agarwal S, Gunjan D, Sehgal T, Aggarwal M, Dhawan R, Gamanagatti S, Shalimar. Thromboelastography-Guided versus Standard-of-Care or On-Demand Platelet Transfusion in Patients with Cirrhosis and Thrombocytopenia Undergoing Procedures: A Randomized Controlled Trial. J Vasc Interv Radiol. 2024;35 10:1508-1518.e2. doi: 10.1016/j.jvir.2024.06.014. 10. Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia. Gastroenterology. 2018;155 3:705-718. doi: 10.1053/j.gastro.2018.05.025. "
[Collapse]
Dai ZS, Zhang M, Deng YY, Zhou N, Tian Y. Efficacy of a novel artificial liver versatile plasma purification system in patients with acute-on-chronic liver failure. World J Gastroenterol 2025; 31(14): 103892
16
"This paper describes a case-control study on the early detection of delayed gastric emptying (gastroparesis), which presents as an ..."
[Read more]
"This paper describes a case-control study on the early detection of delayed gastric emptying (gastroparesis), which presents as an initial symptom of diabetic ketoacidosis (DKA). According to the authors, delayed gastric emptying can frequently cause glycemic variability by delaying postprandial blood glucose elevation, potentially triggering hypoglycemic and hyperglycemic symptoms. This condition increases the risk of DKA and hyperosmolar hyperglycemic syndrome (HHS), with the incidence of DKA being reported as four times higher in patients with delayed gastric emptying. Therefore, the authors emphasize the importance of early diagnosis and appropriate treatment of delayed gastric emptying in patients with DKA. Recently, the possibility of intestinal dysmotility due to dysbiosis caused by uremic toxins in chronic kidney disease (CKD) has also become a topic of interest. Similarly, the relationship between gut microbiota and intestinal motility disorders in DKA patients is an intriguing issue that warrants further investigation. "
[Collapse]
Han L, Peng QY, Yu J, Liu YW, Li W, Ping F, Zhang HB, Li YX, Xu LL. Early detection of gastroparesis with diabetic ketoacidosis as initial manifestation: A case-control study. World J Gastroenterol 2025; 31(15): 101695
17
"This is an interesting study. However, there are a few issues, most of these have been addressed by the authors. Firstly, since this ..."
[Read more]
"This is an interesting study. However, there are a few issues, most of these have been addressed by the authors. Firstly, since this is a retrospective study with a relatively small sample size. Also it is not clear if all patients had a endoscopy to help exclude other causes of delayed gastric emptying. Also the fact that low HbA1c is a predictor needs an adequate explanation. It may be difficult to make conclusions on a sample of only 15 DKA patients. "
[Collapse]
Han L, Peng QY, Yu J, Liu YW, Li W, Ping F, Zhang HB, Li YX, Xu LL. Early detection of gastroparesis with diabetic ketoacidosis as initial manifestation: A case-control study. World J Gastroenterol 2025; 31(15): 101695
18
"Dear Baishideng Office, I read a very interesting article «Management of hepatic encephalopathy following transjugular intrahepatic ..."
[Read more]
"Dear Baishideng Office, I read a very interesting article «Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions». The article format corresponds to the review format. The authors of the review presented the current problem of post-TIPS hepatic encephalopathy. The list of references consists of 155 sources. The article is well illustrated with figures and tables. Easy to read despite the large amount of information material. All problematic sections are analyzed in depth and detail, and modern fields of view for each section are also taken into account. An article worthy of publication in the World Journal of Gastroenterology. "
[Collapse]
Li Y, Wu YT, Wu H. Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions. World J Gastroenterol 2025; 31(15): 103512
19
"This study addresses a critical gap in acute pancreatitis management by systematically comparing established scoring systems with ..."
[Read more]
"This study addresses a critical gap in acute pancreatitis management by systematically comparing established scoring systems with novel hematological markers. The focus on early-phase severity stratification aligns with clinical urgency, as delayed interventions in severe AP significantly worsen outcomes. The inclusion of 463 patients across severity categories provides sufficient statistical power. The use of multivariate logistic regression to identify independent predictors and AUC comparisons for ROC analyses strengthens validity. Notably, the combined PNI48 + Ranson model achieved an AUC of 0.936, outperforming individual parameters. However, the study has several issues that need to be addressed. 1) While CTSI showed the highest individual AUC, its reliance on CT imaging (performed 2–5 days post-admission) limits utility in hyperacute settings. The BISAP score’s superiority over APACHE II/SOFA within 24 h is consistent with prior literature , but the lack of comparison with newer tools is a missed opportunity. 2) The study’s retrospective nature introduces risks of selection bias, particularly in excluding patients with brief hospital stays ( "
[Collapse]
Shi PN, Song ZZ, He XN, Hong JM. Evaluation of scoring systems and hematological parameters in the severity stratification of early-phase acute pancreatitis. World J Gastroenterol 2025; 31(15): 105236
20
"This article presents a series of clinically practical and easily obtainable diagnostic indices, enabling medical professionals to ..."
[Read more]
"This article presents a series of clinically practical and easily obtainable diagnostic indices, enabling medical professionals to more accurately evaluate patient conditions in real-world clinical settings. These indicators are particularly valuable for the early diagnosis and severity assessment of pancreatitis, offering crucial guidance for subsequent treatment decisions. By incorporating these measurable parameters into routine clinical practice, healthcare providers can enhance diagnostic efficiency, improve risk stratification, and facilitate timely therapeutic interventions. The systematic application of these indices not only supports evidence-based medical decision-making but also contributes to standardized patient management protocols, ultimately leading to better clinical outcomes in pancreatitis care. "
[Collapse]
Shi PN, Song ZZ, He XN, Hong JM. Evaluation of scoring systems and hematological parameters in the severity stratification of early-phase acute pancreatitis. World J Gastroenterol 2025; 31(15): 105236
929 items Read more >>
- ALL AUTHOR RESOURCES
- Appeals and Complaints
- Article Processing Charge
- Common Usage of Quantities and Units
- Copyright License Agreement
- Create an Account
- Criteria for Authorship
- Ethics Committee of Baishideng
- Ethics Statements
- Guidelines for Authors
- Journals
- Language Editing Process for Manuscripts Submitted by Non-Native Speakers of English
- Methods of Post-Publication Debate
- Open-Access
- Policies on Handle Allegations from Whistleblowers
- Publication Misconduct
- Quality of Publications
- Steps for Submitting Manuscripts
- Submit a Manuscript
- ALL PEER-REVIEWER RESOURCES
- Manuscript Decision
- Peer-Review Process
- Peer-Reviewer Tracking for Manuscripts
- Reviewer Acknowledgment
- REFERENCE CITATION ANALYSIS
- Find a Category
- Find a Journal
- Find a Scholar
- Find an Academic Assistant
- Find an Article
- Find an Article PDF
- Subscribe
- Today's Articles
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
California Corporate Number: 3537345